The activated clotting time (ACT) is a test that is used primarily to monitor high doses of unfractionated (standard) heparin therapy. Heparin is a drug that inhibits blood clotting (anticoagulant) and is usually given intravenously (IV) by injection or continuous infusion. High doses of heparin may be given during procedures that require that blood be prevented from clotting, such as heart bypass surgery.
The global Activated Clotting Time Testing market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Activated Clotting Time Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Roche
Thermo Fisher Scientific
Abbott
Helena Laboratories
Sysmex
Medtronic
Instrumentation Laboratory
Diagnostica Stago
Werfen
LabCorp
Segment by Type
Optical Detection
Laser-based Detection
Mechanical Detection
Fluorescent Based Detection
Segment by Application
Hospitals
Clinical Laboratories
Ambulatory Surgical Center
Academic & Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Activated Clotting Time Testing report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Activated Clotting Time Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Optical Detection
1.2.3 Laser-based Detection
1.2.4 Mechanical Detection
1.2.5 Fluorescent Based Detection
1.3 Market by Application
1.3.1 Global Activated Clotting Time Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinical Laboratories
1.3.4 Ambulatory Surgical Center
1.3.5 Academic & Research Institutes
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Activated Clotting Time Testing Market Perspective (2018-2029)
2.2 Activated Clotting Time Testing Growth Trends by Region
2.2.1 Global Activated Clotting Time Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Activated Clotting Time Testing Historic Market Size by Region (2018-2023)
2.2.3 Activated Clotting Time Testing Forecasted Market Size by Region (2024-2029)
2.3 Activated Clotting Time Testing Market Dynamics
2.3.1 Activated Clotting Time Testing Industry Trends
2.3.2 Activated Clotting Time Testing Market Drivers
2.3.3 Activated Clotting Time Testing Market Challenges
2.3.4 Activated Clotting Time Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Activated Clotting Time Testing Players by Revenue
3.1.1 Global Top Activated Clotting Time Testing Players by Revenue (2018-2023)
3.1.2 Global Activated Clotting Time Testing Revenue Market Share by Players (2018-2023)
3.2 Global Activated Clotting Time Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Activated Clotting Time Testing Revenue
3.4 Global Activated Clotting Time Testing Market Concentration Ratio
3.4.1 Global Activated Clotting Time Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Activated Clotting Time Testing Revenue in 2022
3.5 Activated Clotting Time Testing Key Players Head office and Area Served
3.6 Key Players Activated Clotting Time Testing Product Solution and Service
3.7 Date of Enter into Activated Clotting Time Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Activated Clotting Time Testing Breakdown Data by Type
4.1 Global Activated Clotting Time Testing Historic Market Size by Type (2018-2023)
4.2 Global Activated Clotting Time Testing Forecasted Market Size by Type (2024-2029)
5 Activated Clotting Time Testing Breakdown Data by Application
5.1 Global Activated Clotting Time Testing Historic Market Size by Application (2018-2023)
5.2 Global Activated Clotting Time Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Activated Clotting Time Testing Market Size (2018-2029)
6.2 North America Activated Clotting Time Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Activated Clotting Time Testing Market Size by Country (2018-2023)
6.4 North America Activated Clotting Time Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Activated Clotting Time Testing Market Size (2018-2029)
7.2 Europe Activated Clotting Time Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Activated Clotting Time Testing Market Size by Country (2018-2023)
7.4 Europe Activated Clotting Time Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Activated Clotting Time Testing Market Size (2018-2029)
8.2 Asia-Pacific Activated Clotting Time Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Activated Clotting Time Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Activated Clotting Time Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Activated Clotting Time Testing Market Size (2018-2029)
9.2 Latin America Activated Clotting Time Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Activated Clotting Time Testing Market Size by Country (2018-2023)
9.4 Latin America Activated Clotting Time Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Activated Clotting Time Testing Market Size (2018-2029)
10.2 Middle East & Africa Activated Clotting Time Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Activated Clotting Time Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Activated Clotting Time Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Activated Clotting Time Testing Introduction
11.1.4 Roche Revenue in Activated Clotting Time Testing Business (2018-2023)
11.1.5 Roche Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Activated Clotting Time Testing Introduction
11.2.4 Thermo Fisher Scientific Revenue in Activated Clotting Time Testing Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Activated Clotting Time Testing Introduction
11.3.4 Abbott Revenue in Activated Clotting Time Testing Business (2018-2023)
11.3.5 Abbott Recent Development
11.4 Helena Laboratories
11.4.1 Helena Laboratories Company Detail
11.4.2 Helena Laboratories Business Overview
11.4.3 Helena Laboratories Activated Clotting Time Testing Introduction
11.4.4 Helena Laboratories Revenue in Activated Clotting Time Testing Business (2018-2023)
11.4.5 Helena Laboratories Recent Development
11.5 Sysmex
11.5.1 Sysmex Company Detail
11.5.2 Sysmex Business Overview
11.5.3 Sysmex Activated Clotting Time Testing Introduction
11.5.4 Sysmex Revenue in Activated Clotting Time Testing Business (2018-2023)
11.5.5 Sysmex Recent Development
11.6 Medtronic
11.6.1 Medtronic Company Detail
11.6.2 Medtronic Business Overview
11.6.3 Medtronic Activated Clotting Time Testing Introduction
11.6.4 Medtronic Revenue in Activated Clotting Time Testing Business (2018-2023)
11.6.5 Medtronic Recent Development
11.7 Instrumentation Laboratory
11.7.1 Instrumentation Laboratory Company Detail
11.7.2 Instrumentation Laboratory Business Overview
11.7.3 Instrumentation Laboratory Activated Clotting Time Testing Introduction
11.7.4 Instrumentation Laboratory Revenue in Activated Clotting Time Testing Business (2018-2023)
11.7.5 Instrumentation Laboratory Recent Development
11.8 Diagnostica Stago
11.8.1 Diagnostica Stago Company Detail
11.8.2 Diagnostica Stago Business Overview
11.8.3 Diagnostica Stago Activated Clotting Time Testing Introduction
11.8.4 Diagnostica Stago Revenue in Activated Clotting Time Testing Business (2018-2023)
11.8.5 Diagnostica Stago Recent Development
11.9 Werfen
11.9.1 Werfen Company Detail
11.9.2 Werfen Business Overview
11.9.3 Werfen Activated Clotting Time Testing Introduction
11.9.4 Werfen Revenue in Activated Clotting Time Testing Business (2018-2023)
11.9.5 Werfen Recent Development
11.10 LabCorp
11.10.1 LabCorp Company Detail
11.10.2 LabCorp Business Overview
11.10.3 LabCorp Activated Clotting Time Testing Introduction
11.10.4 LabCorp Revenue in Activated Clotting Time Testing Business (2018-2023)
11.10.5 LabCorp Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Roche
Thermo Fisher Scientific
Abbott
Helena Laboratories
Sysmex
Medtronic
Instrumentation Laboratory
Diagnostica Stago
Werfen
LabCorp
Ěý
Ěý
*If Applicable.
